RecruitingNot Applicable

Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility

United States100 participantsStarted 2025-12-01

Plain-language summary

The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how the mediodorsal (MD) thalamus encodes and updates "context"-the mental framework that determines which rules or actions are relevant in a given situation. This work may contribute to understanding why certain psychiatric conditions, such as schizophrenia and ADHD, involve difficulties with cognitive flexibility and control. The primary research questions are: Does the MD thalamus represent the context that organizes how working memory guides task selection? Does the MD thalamus signal when context needs to be updated after a change in task demands? Do these thalamic representations support generalization to new situations or rules? Participants will complete cognitive tasks while undergoing high-resolution brain imaging using 7-Tesla MRI. The investigators will combine behavioral data, computational modeling, and advanced neuroimaging analyses to examine how the thalamus interacts with the cortex during flexible decision-making.

Who can participate

Age range

18 Years – 35 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * No history of any neurological, psychiatric, or medical condition that could affect cognition * No use of benzodiazepines, long-acting opioids, or other psychotropic drugs that could alter cognitive performance * Normal or corrected-to-normal vision (visual acuity) * Normal color perception (Farnsworth-Munsell 100 Hue Test) * Fluent in English * No metal implants (including aneurysm clip, cardiac pacemaker, ICD, IUD, neurostimulation system, spinal cord stimulator, internal electrodes or wires, bone stimulator, ear implant, insulin or other infusion pump or device, prosthesis, artificial or prosthetic limb, shunt, vascular access port or catheter, thermodilution catheter, medication patch, radiation seeds or implants, wire mesh implant, tissue expander, surgical staples or clips or sutures, joint replacement, joint/bone pin/screw/nail/wire/plate, dentures, or non-removable hearing aid) * No exposure to shrapnel or other-related MR contraindications * No non-removable body piercing jewelry * No non-removable makeup * No history of claustrophobia * No history of breathing problems * Not currently pregnant or trying to get pregnant (this will be determined via self report and no records will be kept). Exclusion Criteria: * Has a history of any neurological, psychiatric, or medical condition that could affect cognition * Use of benzodiazepines, long-acting opioids, or other psychotropic drugs that could alter cognitive performance * Not fluent in English …

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Decoding of context representations in the medial dorsal thalamus from 7 T MRI data

Timeframe: Measured throughout the MRI session (approximately 90 minutes per participant).

Trial details

NCT IDNCT07217652

SponsorKai Hwang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-06-30

Contact for this trial

Kai Hwang, PhD

319-335-2406 kai-hwang@uiowa.edu

View on ClinicalTrials.gov More Schizophrenia trials